Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Change in Account Payables (2021 - 2025)

Historic Change in Account Payables for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to -$183000.0.

  • Krystal Biotech's Change in Account Payables rose 6903.55% to -$183000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $826000.0, marking a year-over-year decrease of 1829.87%. This contributed to the annual value of $826000.0 for FY2025, which is 1829.87% down from last year.
  • Per Krystal Biotech's latest filing, its Change in Account Payables stood at -$183000.0 for Q4 2025, which was up 6903.55% from -$4.0 million recorded in Q3 2025.
  • In the past 5 years, Krystal Biotech's Change in Account Payables registered a high of $4.1 million during Q2 2025, and its lowest value of -$4.0 million during Q3 2025.
  • In the last 5 years, Krystal Biotech's Change in Account Payables had a median value of $99000.0 in 2023 and averaged $59700.0.
  • As far as peak fluctuations go, Krystal Biotech's Change in Account Payables soared by 57943.93% in 2024, and later plummeted by 451758.24% in 2025.
  • Over the past 5 years, Krystal Biotech's Change in Account Payables (Quarter) stood at $937000.0 in 2021, then crashed by 200.11% to -$938000.0 in 2022, then soared by 76.33% to -$222000.0 in 2023, then plummeted by 166.22% to -$591000.0 in 2024, then surged by 69.04% to -$183000.0 in 2025.
  • Its Change in Account Payables stands at -$183000.0 for Q4 2025, versus -$4.0 million for Q3 2025 and $4.1 million for Q2 2025.